$OLMA 4 SEC Filings

Filed On	Filing
02 Sep 2026	Form 4: O'Byrne Jason, CHIEF FINANCIAL OFFICER Granted 650,000 Stock Option (Right to Buy)
27 Jul 2026	Form 4: Harmon Cyrus, Director Sold 12,500 shares ($145K) · Sold 12,500 shares ($146K)
23 Jun 2026	Form 4: Harmon Cyrus, Director Granted 29,500 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Butitta Cynthia M, Director Granted 29,500 Stock Option (right to buy)
23 Jun 2026	Form 4: Garland J. Scott, Director Granted 29,500 Stock Option (right to buy)
23 Jun 2026	Form 4: Hrustanovic Gorjan, Director Granted 29,500 Stock Option (right to buy)
23 Jun 2026	Form 4: Clark Ian T, Director Granted 29,500 Stock Option (right to buy)
23 Jun 2026	Form 4: Larson Yi, Director Granted 29,500 Stock Option (right to buy)
23 Jun 2026	Form 4: Horning Sandra, Director Granted 29,500 Stock Option (right to buy)
23 Jun 2026	Form 4: Raman Prakash, Director Granted 29,500 Stock Option (right to buy)
23 Jun 2026	Form 4: Rappaport Andrew, Director Granted 29,500 Stock Option (right to buy)
23 Jun 2026	Form 4: Graham G. Walmsley, Director Granted 29,500 Stock Option (right to buy)
23 Jun 2026	Form 4: Bvf Partners L P/IL, Director and 9 others Granted 29,500 Stock Option (Right to buy)
29 Apr 2026	Form 4: Raman Prakash, Director Granted 27,061 Stock Option (Right to Buy)
05 Mar 2026	Form 4: Mitchell Shawnte, CHIEF LEGAL OFFICER Received 15,000 shares by exercise or conversion ($65.6K) · Sold 15,000 shares ($345K) · Received 25,000 shares by exercise or conversion ($109K) · 2 more
17 Feb 2026	Form 4: Austin Sasha Lu, VP of Finance and Controller Received 11,700 shares as a grant or award · Granted 29,250 Stock Option (Right to Buy)
04 Feb 2026	Form 4: Zojwalla Naseem, CHIEF MEDICAL OFFICER Granted 250,000 Stock Option (Right to Buy) · Granted 106,250 Performance Stock Options (Right to Buy)
04 Feb 2026	Form 4: Myles David C., CH. DISCOV. & NON-CLIN DEV OFF Granted 250,000 Stock Option (Right to Buy) · Granted 106,250 Performance Stock Options (Right to Buy)
04 Feb 2026	Form 4: Mitchell Shawnte, CHIEF LEGAL OFFICER Granted 220,000 Stock Option (Right to Buy) · Granted 56,250 Performance Stock Options (Right to Buy)
04 Feb 2026	Form 4: Bohen Sean, Director Granted 850,000 Stock Option (Right to Buy) · Granted 275,000 Performance Stock Options (Right to Buy)

Comments